Navigation

Viibryd vs. Drizalma Sprinkle

Are Viibryd and Drizalma Sprinkle the Same Thing?

Viibryd (vilazodone hydrochloride) and Drizalma Sprinkle (duloxetine delayed-release capsules) and are antidepressants used to treat depression.

Drizalma Sprinkle is also used to treat generalized anxiety disorder in adults and pediatric patients ages 7 years to 17 years old, diabetic peripheral neuropathic pain in adults, and chronic musculoskeletal pain in adults.

Viibryd and Drizalma Sprinkle are different types of antidepressants. Drizalma Sprinkle is a serotonin and norepinephrine reuptake inhibitor (SNRI) and Viibryd is a selective serotonin reuptake inhibitor (SSRI).

Side effects of Viibryd and Drizalma Sprinkle that are similar include nausea.

Side effects of Viibryd that are different from Drizalma Sprinkle include dry mouth, drowsiness, constipation, decreased appetite, and increased sweating.

Side effects of Drizalma Sprinkle that are different from Viibryd include diarrhea, vomiting, and sleep problems (insomnia).

Both Viibryd and Drizalma Sprinkle may interact with alcohol, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, other antidepressants, migraine headache medicines, blood thinners, St. John's wort, fentanyl, and tramadol.

Viibryd may also interact with other drugs that make you sleepy or slow your breathing (sleeping pills, narcotics, prescription cough medicines, muscle relaxers, or medicines for anxiety or seizures), diuretics (water pills), mephenytoin, medicines to treat ADHD or narcolepsy, and medicines to treat anxiety, mood disorders, thought disorders, or mental illness.

Drizalma Sprinkle may also interact with monoamine oxidase inhibitors (MAOIs), lithium, tryptophan, buspirone, amphetamines, cimetidine, ciprofloxacin, enoxacin, quinidine, phenothiazines, type 1C antiarrhythmics, aluminum-and magnesium-containing antacids, famotidine, proton pump inhibitors (PPIs), theophylline, caffeine, centrally acting CNS drugs, and highly plasma protein binding drugs.

What Are Possible Side Effects of Viibryd?

Common side effects of Viibryd include:

What Are Possible Side Effects of Drizalma Sprinkle?

Common side effects of Drizalma Sprinkle include:

  • nausea,
  • dry mouth,
  • drowsiness,
  • constipation,
  • decreased appetite, and
  • increased sweating

What Is Viibryd?

Viibryd (desvenlafaxine) is type of antidepressant called a selective serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat major depressive disorder.

What Is Drizalma Sprinkle?

Drizalma Sprinkle (duloxetine delayed-release capsules) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for major depressive disorder in adults, generalized anxiety disorder in adults and pediatric patients ages 7 years to 17 years old, diabetic peripheral neuropathic pain in adults, and chronic musculoskeletal pain in adults.

What Drugs Interact With Viibryd?

Viibryd may interact with cold or allergy medicines, sedatives, narcotics, sleeping pills, muscle relaxers, medicines for seizures or anxiety, other antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDs), blood thinners, St. John's wort, tramadol, L-tryptophan, heart medications, or medicines to treat migraines.

Viibryd may also interact with diuretics (water pills), linezolid, lithium, metoclopramide, midazolam, antibiotics, antifungals, blood pressure medications, or HIV/AIDS medicines.

What Drugs Interact With Drizalma Sprinkle?

Drizalma Sprinkle may interact with monoamine oxidase inhibitors (MAOIs), triptans, tricyclic antidepressants, other SNRIs or SSRIs, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, St. John's wort, cimetidine, ciprofloxacin, enoxacin, nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin, warfarin, quinidine, phenothiazines, type 1C antiarrhythmics, aluminum-and magnesium-containing antacids, famotidine, proton pump inhibitors (PPIs), theophylline, caffeine, centrally acting CNS drugs, highly plasma protein binding drugs, and alcohol. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Drizalma Sprinkle; third trimester use may increase risk of symptoms of poor adaptation (respiratory distress, temperature instability, feeding difficulty, low muscle tone, tremor, irritability) in newborns. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. Drizalma Sprinkle passes into breast milk but its effects on nursing infants are unknown. Consult your doctor before breastfeeding.

How Should Viibryd Be Taken?

The recommended dose for Viibryd is 50 mg once daily, with or without food.

How Should Drizalma Sprinkle Be Taken?

The dose of Drizalma Sprinkle is 60 mg daily for most conditions.

Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.